Company: CCNE
Filing Date: 2025-03-05
Form Type: 424B3
Source: 0001193125-25-047258
Chunk: 220

Company: CNB FINANCIAL CORP/PA
Filing Date: 2025-03-05
Form: 424B3
Chunk 220
---
 or regulations of general applicability to financial institutions and/or their holding                                                                                                                                             
 companies, or interpretations thereof by courts or any bank regulator or governmental authorities, except to the extent that the effects of such change are materially disproportionately adverse to the business, properties, assets, liabilities, 
 results of operations or financial condition of such party and its subsidiaries, taken as a whole, as compared to other companies in the financial services industry;                                                                               |

| • |     | changes in global, national or regional political conditions (including the outbreak of war or acts of terrorism)                                                                                                                                        
 or in economic or market (including equity, credit and debt markets, as well as changes in interest rates) conditions affecting the financial services industry generally and not specifically relating to such party or its subsidiaries (including any 
 such changes arising out of the pandemic or any pandemic measures), except to the extent that the effects of such change are materially disproportionately adverse to the business, properties, assets, liabilities, results of operations or financial  
 condition of such party and its subsidiaries, taken as a whole, as compared to other companies in the financial services industry;                                                                                                                       |

| • |     | changes resulting from hurricanes, earthquakes, tornados, floods or other natural disasters or from any outbreak 
 of any disease or other public health event (including the pandemic);                                            |

| • |     | public disclosure of the execution of the merger agreement, public disclosure or consummation of the transactions                                                                                                                             
 contemplated under the merger agreement (including any effect on a party’s relationships with its customers or employees) or actions expressly required by the merger agreement or actions or omissions that are taken with the prior written 
 consent of the other party in contemplation of the transactions contemplated under the merger agreement;                                                                                                                                      |

169

| • |     | a decline in the trading price of a party’s common stock or the failure, in and of itself, to meet earnings                                                                                                     
 projections or internal financial forecasts (it being understood that the underlying cause of such decline or failure may be taken into account in determining whether a material adverse effect has occurred); |

| • |     | actions and omissions of either party taken with the prior written consent, or at the request, of the other; or |

| • |     | the expenses incurred by either party in investigating, negotiating, documenting, effecting and consummating the 
 transactions contemplated by the merger agreement.                                                               |

Termination The merger agreement may be terminated, and the merger and the transactions contemplated by the merger agreement abandoned as follows:

| •